The MRPS28 antibody is a tool used to detect mitochondrial ribosomal protein S28 (MRPS28), a component of the small subunit (28S) of the mitochondrial ribosome. Mitochondrial ribosomes are essential for translating mitochondrial DNA-encoded mRNAs, producing proteins critical for oxidative phosphorylation (OXPHOS) and cellular energy metabolism. MRPS28 plays a structural or functional role in ribosome assembly, ensuring proper synthesis of electron transport chain (ETC) complexes. Dysregulation of mitochondrial ribosomal proteins, including MRPS28. is linked to mitochondrial disorders, cancer, and neurodegenerative diseases.
Antibodies against MRPS28 enable researchers to study its expression, localization, and interactions via techniques like Western blotting, immunofluorescence, and immunohistochemistry. These studies help elucidate its role in mitochondrial dysfunction and disease mechanisms. For example, reduced MRPS28 levels may impair mitochondrial translation, leading to ETC deficiencies and metabolic stress. In cancer, altered MRPS28 expression has been observed in certain tumors, suggesting potential as a biomarker or therapeutic target.
Commercial MRPS28 antibodies are typically validated for specificity across human and model organisms, supporting research in mitochondrial biology and pathology. Understanding MRPS28's function contributes to insights into cellular energy regulation and disease pathways involving mitochondrial protein synthesis.